Abu Dhabi: Special measures for participants in clinical trials

The Abu Dhabi Emergency, Crisis and Disasters Committee for Covid-19 Pandemic has approved special measures for participants in the Phase III clinical trials of the vaccine or the National Vaccination Programme.

Vaccine trial participants are identified by a gold star in the Alhosn app. When travelling from abroad, they must take a PCR test before travelling and upon entry into the emirate but are not required to quarantine.

Participants in the vaccination programme are identified by the letter E in the Alhosn app. When travelling from abroad, they must take a PCR test before travelling, upon entry into the emirate and on the 4th and 8th days after entry. They are not required to quarantine.

All participants are not required to take a test to enter from within the UAE. The special measures are only valid if the participant’s Alhosn app shows their special status, which is linked to taking a PCR test every fortnight.